Vitalys Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
as on 07-12-2024
- Revenue 1.67%
(FY 2022)
- Profit 916.64%
(FY 2022)
- Ebitda 939.65%
(FY 2022)
- Net Worth 243.33%
(FY 2022)
- Total Assets -40.93%
(FY 2022)
About Vitalys Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M.
Deepak Goyal and Pallavi Goyal serve as directors at the Company.
- CIN/LLPIN
U24232PB2014PTC038951
- Company No.
038951
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Moga, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vitalys Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Goyal  | Director | 18-Mar-2023 | Current |
| Pallavi Goyal | Director | 18-Mar-2023 | Current |
Financial Performance of Vitalys Pharmaceuticals.
Vitalys Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.67% increase. The company also saw a substantial improvement in profitability, with a 916.64% increase in profit. The company's net worth Soared by an impressive increase of 243.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitalys Pharmaceuticals?
In 2022, Vitalys Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Oct 2023 | ₹9.00 M | Open |
How Many Employees Work at Vitalys Pharmaceuticals?
Vitalys Pharmaceuticals has a workforce of 6 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitalys Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitalys Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
